TheraRadar
← Back
Data updated: Mar 29, 2026

NANG KUANG PHARM CO

OncologyInfectious DiseaseDermatology
Generics

NANG KUANG PHARM CO is a generic drug manufacturer focused on Oncology, Infectious Disease, Dermatology.

2016
Since
5
Drugs
-
Trials
76
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 33%
1 drugs
Infectious Disease 33%
1 drugs
Dermatology 33%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology